Gastrointestinal Adverse Drug Reaction Profile of Etanercept: Real-world Data From Patients and Healthcare Professionals.

Jette A van LintNaomi T JessurunSander W TasBart J F van den BemtMichael T NurmohamedMartijn B A van DoornPhyllis I SpulsAstrid M van TubergenPeter M Ten KloosterEugene P van PuijenbroekFrank HoentjenHarald E Vonkeman

Published in: The Journal of rheumatology (2021)

Most GI-ADRs associated with ETN concerned gastrointestinal symptoms. These ADRs may lead to dose adjustment or ETN discontinuation. The frequency of ETN-associated GI-ADRs was comparable to the frequency of ADA-associated GI-ADRs. Knowledge about these previously unknown ADRs can facilitate early recognition and improve patient communication.

Keyphrases

adverse drug
end stage renal disease
electronic health record
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
rheumatoid arthritis
case report
emergency department
patient reported outcomes
machine learning
juvenile idiopathic arthritis
drug induced
deep learning
disease activity